Scandion Oncology investor relations material

Listen to the latest call from Scandion Oncology

Scandion Oncology A/S is a clinical-stage biotechnology company, which focuses on developing medicines for the treatment of chemotherapy resistance. Scandion Oncology A/S was founded in 2017 and is headquartered in Copenhagen, Denmark.

Dig deeper into the Scandion Oncology fundamentals on Quartr.